HomeCompareCLXT vs NOBL

CLXT vs NOBL: Dividend Comparison 2026

CLXT yields 31.75% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLXT wins by $123.4K in total portfolio value
10 years
CLXT
CLXT
● Live price
31.75%
Share price
$6.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$146.3K
Annual income
$20,332.14
Full CLXT calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — CLXT vs NOBL

📍 CLXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLXTNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLXT + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLXT pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLXT
Annual income on $10K today (after 15% tax)
$2,698.41/yr
After 10yr DRIP, annual income (after tax)
$17,282.32/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, CLXT beats the other by $17,070.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLXT + NOBL for your $10,000?

CLXT: 50%NOBL: 50%
100% NOBL50/50100% CLXT
Portfolio after 10yr
$84.6K
Annual income
$10,290.96/yr
Blended yield
12.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLXT right now

CLXT
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Altman Z
-4.9
Piotroski
3/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLXT buys
0
NOBL buys
0
No recent congressional trades found for CLXT or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLXTNOBL
Forward yield31.75%2.17%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$146.3K$22.9K
Annual income after 10y$20,332.14$249.78
Total dividends collected$102.0K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CLXT vs NOBL ($10,000, DRIP)

YearCLXT PortfolioCLXT Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$13,875$3,174.60$10,917$217.08+$3.0KCLXT
2$18,962$4,116.48$11,903$221.48+$7.1KCLXT
3$25,548$5,257.91$12,962$225.68+$12.6KCLXT
4$33,956$6,620.46$14,099$229.68+$19.9KCLXT
5$44,557$8,223.86$15,319$233.49+$29.2KCLXT
6$57,761$10,085.28$16,628$237.10+$41.1KCLXT
7$74,023$12,218.70$18,033$240.53+$56.0KCLXT
8$93,839$14,634.31$19,539$243.78+$74.3KCLXT
9$117,746$17,338.22$21,154$246.86+$96.6KCLXT
10$146,321$20,332.14$22,884$249.78+$123.4KCLXT

CLXT vs NOBL: Complete Analysis 2026

CLXTStock

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Full CLXT Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this CLXT vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLXT vs SCHDCLXT vs JEPICLXT vs OCLXT vs KOCLXT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.